NEWS
-
2022年10月25日上午，道合药业与中泰证券签订IPO上市辅导协议。东营港经济开发区财政金融局副局长郭树壮，道合药业董事长宋伟国，中泰证券投行委副主任、战略客户部总经理朱锋，中泰证券东营分公司总经理周顺远，中泰证券投行委执行总经理、成长企业融资部副总经理王作维，东营港经济开发区滨海精细化工产业园副主任王瑞，以及道合药业总监以上管理层干部、中泰证券的嘉宾出席了此次签约仪式，共同见证了道合药业IPO上市挂牌启动仪式这一激动人心的时刻。 道合药业今年1-9月营业收入同比增长89%、出口创汇同比增长61%，标志着公司经过5年的发展，500人的创业团队进入稳定成长期；投资2亿元的南生产区预计将在60天后试生产，标志着总占地面积1000亩道合产业园的第二个生产工厂将正式投入运营；今年相继获得“引进国家级重点人才”、国家“专精特新”小巨人等荣誉，标志着道合药业迈出了 “向全球一流生物医药人才团队建设”的关键一步。 尤其值...
-
2022年9月29日山东省工信厅公示了山东省第四批专精特新“小巨人”企业名单，山东道合药业有限公司名列其中。 专精特新“小巨人”企业是指位于产业基础核心领域、产业链关键环节，创新能力突出、掌握核心技术、细分市场占有率高、质量效益好的优质中小企业。申报企业需同时满足专、精、特、新、链、品六个方面指标，经国家工信部条件论证、部门会审、专家审核、公示等多个流程，最后给予认定，是全国中小企业评定工作中的最高等级、最具权威的荣誉称号。 山东道合药业被认定为国家级专精特新“小巨人”企业，是对公司专业化、精细化、特色化、新颖化的认可，也是对公司研发创新能力及综合实力的认可。同时为进一步提升公司品牌知名度以及在行业内的核心竞争力，实现IPO挂牌打下了坚实的基础。...
-
2022年8月18日山东省工业和信息化厅公布了第六批山东省制造业单项冠军名单，山东道合药业有限公司作为冠军企业入选。 山东省制造业单项冠军企业是指长期专注于某些特定细分产品市场，生产技术、工艺国内领先，产品质量精良，市场占有率位居全省乃至全国前列的企业，代表了全省细分行业最高发展水平。该奖项的评选，旨在为引导制造企业专注创新和产品质量提升，推动产业迈向中高端，带动中国制造走向世界。 道合药业的成功入选是对公司技术创新、品牌价值、行业地位及企业综合实力的认可及肯定，有助于提升公司品牌影响力。公司始终坚持以发展为核心，在节能减排、技术研发、绿色化工、智能化改造等层面积极探索和革新，不断为医药行业发展创造新局面。...
Products
In line with the attitude of being responsible for customers, employees, shareholders and society, Harwaypharma strictly implements the construction of GMP, EHS and intelligence systems to ensure the sustainable development of the enterprise.
About Us
Harway works with you to protect your health
Harwaypharma Co., Ltd., founded in 2017, is a national high-tech enterprise, a national "specialized and new" small giant enterprise, a national "chemical medicine CDMO integrated service platform" demonstration enterprise, a champion of the single manufacturing industry in Shandong Province, and a gazelle enterprise in Shandong Province.
At present, Harwaypharma has completed the strategic development layout of "one place, three parks and two centers". "One site, three parks" is the construction of three production plants in Dongying City, forming an industrial park with a total area of more than 1000 mu. "Two centers" refer to the construction of Shandong Daohe Medical Research Institute and Daohe (Shandong University) R&D center in Dongying City and Jinan City respectively. It will achieve the development goal of "pharmaceutical intermediates - raw materials - preparations" integration and internationalization of generic drugs; Create an assembly line model of "discovery, research and development, production" of innovative drugs.
Year
Time of establishment
Mu
Floor area of production plant
m²
Floor area of laboratory
More than
Existing full-time R&D personnel
Kinds
Up to 300 kinds of listed products
System
Innovation and entrepreneurship for human health
The technology center is based on strivers, attracting and forming a group of experienced technology research and development and management teams. The technical team now has more than 100 full-time R&D personnel.
The company is committed to providing customers with highly innovative and flexible project solutions.
